Assessing the Turkish DDIVAT for Visual Acuity Measurement
NCT ID: NCT07240480
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-12-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Does the Turkish version of the DDIVAT provide reliable and valid visual acuity measurements in Turkish speakers?
Are the results of the DDIVAT comparable to those obtained with the standard Snellen chart used in clinical practice?
Researchers will compare DDIVAT visual acuity test results with Snellen chart results to see if both methods produce consistent measurements.
Participants will:
Be adults aged 18 years or older, including both patients and healthy volunteers.
Undergo visual acuity testing using the DDIVAT system displayed on a smart TV connected to the university server.
Have their visual acuity re-measured using the standard Snellen optotype under the same conditions.
No medication or invasive procedure will be used. The study carries no risk to participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of DDIVAT Digital Optotypes for Distance Visual Acuity Testing Among the Bulgarian Population
NCT07208838
The Effect of Eye Exercises in Individuals With Eye Refractive Defects
NCT05999552
A Web-based Digital Distance Visual Acuity Test
NCT04756596
Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People
NCT07297810
Comparison of a Smartphone Based Self Refraction Tool With Conventional Refraction Error Estimation Methods
NCT03419351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The DDIVAT visual acuity test was originally developed and validated at Democritus University of Thrace (Greece) and has been approved by the National Medicines Organization as a Class I medical device. The current study aims to determine whether the Turkish-translated version of this visual acuity measurement tool performs consistently and accurately among Turkish-speaking participants.
Visual acuity is one of the most fundamental components of a comprehensive ophthalmological examination. It measures the clarity or sharpness of vision, which can be influenced by refractive errors and a variety of ocular diseases. Accurate and accessible tools for measuring visual acuity are therefore essential in both clinical and research settings.
In this study, 200 adult participants (aged 18 years and older) will be recruited from Trakya University Hospital, Department of Ophthalmology (Edirne, Türkiye). The study population will include both healthy volunteers and patients presenting to the ophthalmology clinic.
Each participant will undergo two visual acuity measurements under standardized conditions:
DDIVAT visual acuity test (Turkish version), administered via a smart TV connected to the university's secure server.
Snellen chart test, which represents the standard clinical practice currently used at Trakya University Hospital.
Measurements will be taken monocularly (each eye tested separately) while participants wear their current optical correction (e.g., eyeglasses or contact lenses).
The study will compare the two measurement methods to determine:
The level of agreement between DDIVAT and Snellen test results.
The test-retest reliability of the Turkish DDIVAT.
Since no medication, invasive procedure, or experimental intervention will be applied, the study poses no potential risk to participants. All procedures will comply with the Declaration of Helsinki, Good Clinical Practice (GCP) principles, and relevant data protection regulations.
Collected data will be stored anonymously and used solely for research purposes. The findings are expected to provide evidence supporting the use of DDIVAT as a reliable digital visual acuity tool for Turkish-speaking populations, enhancing accessibility and standardization of visual testing in both clinical and teleophthalmology contexts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants Undergoing Visual Acuity Testing
All enrolled participants (n = 200) will complete two visual acuity measurements during a single visit: one using the DDIVAT (Digital Device Independent Visual Acuity Test) Turkish version and one using the standard Snellen chart. The study compares the agreement and test-retest reliability of these two methods. No intervention, medication, or treatment is applied.
DDIVAT Visual Acuity Test (Turkish Version)
Participants' visual acuity will be measured using the Turkish version of the DDIVAT digital visual acuity device and compared with Snellen chart results. No treatment or invasive procedure will be performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DDIVAT Visual Acuity Test (Turkish Version)
Participants' visual acuity will be measured using the Turkish version of the DDIVAT digital visual acuity device and compared with Snellen chart results. No treatment or invasive procedure will be performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Turkish-speaking individuals able to understand the study purpose
Willingness to participate and provide written informed consent
Participants with or without refractive errors (e.g., myopia, hyperopia, astigmatism)
Exclusion Criteria
Individuals unable to complete visual acuity testing
Presence of severe ocular pathology (e.g., corneal opacity, retinal detachment) that prevents accurate measurement
Cognitive or communication difficulties preventing informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trakya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Hande Guclu
Department Head - Ophthalmology (Trakya Univ.)-Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hande Güçlü, M.D., Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Trakya University Faculty of Medicine Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Posar A, Visconti P. Early Motor Impairment in Children with Autism Spectrum Disorder. Turk Arch Pediatr. 2021 Nov;56(6):646-647. doi: 10.5152/TurkArchPediatr.2021.21168. No abstract available.
Daiber HF, Gnugnoli DM. Visual Acuity. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK563298/
Related Links
Access external resources that provide additional context or updates about the study.
Official site of the DDIVAT (Digital Device Independent Visual Acuity Test) developed at Democritus University of Thrace, Greece.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Turkish DDIVAT TrakyaUni
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.